Senior Executive – Regulatory Affairs
Regulatory affairs professional with an M.Pharm in Regulatory Affairs
Understanding the difference between SiMD and SaMD is critical for any digital health company navigating global medical device compliance. While Software in a Medical Device (SiMD) and Software as a Medical Device (SaMD) sound similar, they represent fundamentally distinct software architectures, regulatory pathways, risk profiles, and submission requirements.
Misclassifying your digital health product early in the medical device product design and development phase can result in rejected technical files, delayed market entry, and unnecessary regulatory rework.
Defining SiMD vs. SaMD: Core Architectural Differences
To understand the regulatory implications, you must first distinguish between embedded software and standalone medical software:
What is SiMD (Software in a Medical Device)?
SiMD—often referred to as embedded software or firmware—is software that forms an integral part of a physical medical device hardware. It directly drives, controls, or reads data from the physical system to achieve the device’s intended medical purpose.
Examples: Software controlling an infusion pump, embedded code inside a cardiac pacemaker, firmware inside an automated blood analyzer, or software driving an MRI scanner.
What is SaMD (Software as a Medical Device)?
As defined by the International Medical Device Regulators Forum (IMDRF), SaMD is software intended to be used for one or more medical purposes that performs these functions without being part of a hardware medical device. It operates on general-purpose computing platforms (cloud servers, mobile phones, desktop computers).
Examples: AI-driven diagnostic image analysis apps, clinical decision support software (CDSS), standalone ECG diagnostic algorithms, and digital therapeutics.
Key Comparison: SiMD vs. SaMD At a Glance
| Regulatory & Functional Aspect | SiMD (Software in a Medical Device) | SaMD (Software as a Medical Device) |
| Hardware Dependency | Bound to dedicated physical hardware. | Hardware-independent; runs on commercial-off-the-shelf (COTS) devices or cloud systems. |
| Regulatory Evaluation | Evaluated together with hardware as a single combined device system. | Evaluated purely as a standalone software product. |
| Classification Driver | Inherits the risk classification of the parent hardware device. | Classified based on clinical situation severity and software decision impact (IMDRF framework). |
| Primary Standard | IEC 62304 integrated with hardware safety standards (IEC 60601-1). | IEC 62304, IEC 82304-1, cybersecurity, and clinical performance evaluation. |
| Cybersecurity Vulnerability | Moderate (primarily physical interface & local network entry points). | High (cloud infrastructure, mobile app stores, public API connections). |
Critical Regulatory Differences You Must Plan For
Device Risk Classification & Approval Pathways
The primary difference between SiMD and SaMD lies in how regulatory bodies establish risk categories:
SiMD Classification: Follows the risk tier of the host hardware. If an infusion pump is a Class IIb device under EU MDR or Class II under US FDA 510(k), the embedded SiMD shares that exact classification.
SaMD Classification: Regulated independently using clinical evaluation frameworks. Under US FDA guidance, EU MDR Rule 11, and India’s CDSCO registration for software as a medical device, SaMD risk depends on whether the software drives direct clinical treatment, informs diagnostic decisions, or provides general health monitoring.
Get expert classification support.
Applicable Software Lifecycle Standards (IEC 62304 & ISO 13485)
Both software types require compliance with IEC 62304 (Medical Device Software Lifecycle Processes). However, implementation differs:
Software Safety Classification: You must classify software items into Class A (no injury), Class B (non-serious injury), or Class C (death/serious injury) based on potential hazard severity.
Quality Management System Integration: Developing compliant software requires a robust QMS for SiMD and SaMD under ISO 13485 and FDA 21 CFR Part 820 / QMSR standards.
Verification, Validation, and Clinical Evidence
Software verification (proving software was built correctly) and validation (proving software meets user needs) are mandatory for both pathways. However, SaMD demands substantially more standalone clinical evaluation and real-world performance data to prove diagnostic accuracy and clinical efficacy. Establishing rigorous medical device software validation and verification protocols is essential before submitting your technical file to Notified Bodies or the FDA.
Software Updates, Change Management, and Cybersecurity
Handling Software Modifications
For SiMD: Firmware updates usually require re-validating the full hardware-software system. Major changes often mandate a new 510(k) or EU MDR technical file amendment.
For SaMD: Frequent updates (e.g., continuous AI model retraining, UI bug fixes) require clear change control protocols. Manufacturers can leverage the FDA’s Predetermined Change Control Plan (PCCP) to pre-clear planned algorithm updates without filing repeated new submissions.
Cybersecurity and Data Integrity Expectations
Because SaMD products connect directly to public networks, cloud APIs, and consumer mobile operating systems, regulators expect strict adherence to FDA pre-market/post-market cybersecurity guidance, Software Bill of Materials (SBOM) generation, encryption, and threat modeling.
Navigating Digital Health Approvals with Operon Strategist
Building compliant medical device software requires clear strategy from software architecture to global submission. Operon Strategist guides software developers, medical device manufacturers, and healthtech startups through every phase of the regulatory process:
Regulatory Classification & Strategy: We analyze your product’s intended use to accurately classify your software as SiMD or SaMD across US FDA, EU MDR, UKCA, and CDSCO India markets.
IEC 62304 & ISO 14971 Integration: Our team designs software lifecycle documentation, risk management files, and safety classifications tailored to your software architecture.
QMS Implementation for Software: We set up scalable ISO 13485 and 21 CFR Part 820 compliant Quality Management Systems covering software change control, configuration management, and post-market surveillance.
Software Validation & Verification (V&V): We build audit-ready V&V test protocols, trace matrices, and performance reports to demonstrate software safety and reliability.
Global Dossier Preparation & Submissions: From FDA 510(k) clearances and De Novo requests to EU MDR Technical Documentation and CDSCO registration, we ensure end-to-end dossier approval.
FAQ's
What is the main difference between SiMD and SaMD?
SiMD is software embedded inside a hardware medical device, while SaMD is standalone software that performs medical functions on general-purpose hardware.
Does SaMD require a physical medical device to operate?
No, SaMD runs independently on general computing platforms like smartphones, cloud servers, or desktop computers.
Do both SiMD and SaMD follow IEC 62304?
Yes, both must comply with IEC 62304 for software lifecycle processes, safety classification, and risk management.
How is SaMD classified under FDA and EU MDR?
SaMD classification depends on its intended clinical purpose, the severity of the medical condition, and the impact of the software output on patient care.
Is AI diagnostic software considered SiMD or SaMD?
If the AI software operates independently without requiring specific physical device hardware, it is classified as SaMD.
Senior Executive – Regulatory Affairs
Regulatory affairs professional with an M.Pharm in Regulatory Affairs, specializing in medical device registration, regulatory documentation, and regulatory requirements. Her expertise includes regulatory submission support and medical device compliance with applicable international standards.
